ArticleIBRO neuroscience reports2026
Involvement of D1- and D2-like dopamine receptors in the hippocampal CA1 region in mediating the restraint stress-induced analgesia in the rats.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute stress exposure can elicit analgesic responses in multiple pain models. Research indicates that dopaminergic pathways in the hippocampus contribute to the analgesic responses elicited by forced swim stress, considered a combination of physical and psychological stress. Since psychological and physical stresses can trigger different brain pathways and areas, this study has examined how dopaminergic receptors in the CA1 region of the hippocampus affect the pain relief induced by restraint stress (RS), generally considered a psychological stress, in an acute pain model. Ninety-six Wistar rats underwent stereotaxic surgery, during which a cannula was unilaterally implanted in the CA1 region of the hippocampus. Five minutes prior to exposure to RS, D1- and D2-like dopamine receptor antagonists (SCH23390 and sulpiride, respectively) or their respective carriers, saline and DMSO, were administered in different doses (0.25, 1, and 4 µg/0.5 µl per rat) into the CA1 area. The analgesic effects of RS were examined with and without dopaminergic receptor antagonists using the tail-flick test. This study's findings indicated that the administration of SCH23390 and sulpiride into the CA1 area of the hippocampus at the maximal doses (4 µg/0.5 µl;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.